Nice ADR earnings beat by $0.06, revenue topped estimates

Nice ADR (NASDAQ: NICE) reported Q3 EPS of $2.84, beating estimates by $0.06, with revenue at $790.7M, surpassing expectations. The company provided FY 2026 guidance, with EPS and revenue estimates slightly below consensus. The stock is up 4.34% over 3 months but down 17.84% year-over-year. InvestingPro rates its financial health as 'great performance'.

Original reporting
Published Nov 4, 2026, 10:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NICE
Bullish
high confidence
Mentioned
$NICE
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NICEBullishHigh
01

Why it matters

The earnings beat and guidance may prompt a modest price increase, especially in after-hours trading.

02

Market read

First-report earnings beat with guidance; relevant for traders holding or considering NICE.

03

What to watch

Potential headwinds from macro slowdown could temper the positive reaction.

Relevance 7/10Novelty 8/10Timing: after-hours reaction

Background

Nice ADR (NASDAQ:NICE) released its third-quarter earnings, beating consensus EPS by $0.06 and providing FY 2026 guidance.

Company-level read

Ticker impact

$NICEBullishHigh confidence
Context

Nice ADR reported Q3 EPS of $2.84, beating estimates by $0.06 and provided FY 2026 guidance.

Expected impact

likely modest upward pressure as investors price in the beat and guidance

Evidence & confidence

The beat is small but positive; guidance is in line with consensus, supporting a slight bullish bias.

Market effects

May lift sentiment for the broader software/services sector.

Limited to US-listed ADR investors.

Low; impact confined to Nice ADR shareholders.

Counterpoint

The beat is marginal; investors may already price in the guidance, limiting upside.

Key entities

  • Nice ADR

    Software and services provider listed on NASDAQ.

Related articles

$NICEMed

NiCE Cognigy Adds Reusable Skills, Decision Tracing

NiCE launched an updated AI agent platform with features like reusable skills, decision tracing, and integrations with OpenAI, Anthropic, and others. The company aims to help enterprises scale AI agents across customer journeys. NiCE reported Q3 2026 revenue of $790.7 million and AI ARR of $392 million, maintaining full-year guidance of $3.17–$3.19 billion.

$NICEMedAI 8/10

NICE Ltd (NICE) (Q3 2026) Earnings Call Highlights: AI ARR Jumps 46% as Revenue Tops Guidance

NICE Ltd (NICE) reported Q3 2026 earnings, with AI ARR up 46% and revenue exceeding guidance. Cloud revenue grew 10.6% YoY, but management expressed dissatisfaction. The company plans a 5% workforce reduction, with $15-20M in restructuring charges. Free cash flow margin outlook was lowered to 10-12%. CEO Scott Russell remains confident in cloud growth reacceleration, citing AI and international market growth.

$NICEHighAI 8/10

NICE (NICE) Q3 2026 Earnings Call Transcript

NICE reported Q3 2026 revenue of $791M and non-GAAP EPS of $2.84, exceeding guidance. Cloud revenue grew 10.6% (12.2% excluding a customer credit), with AI ARR up 46% YoY. The company is focusing on accelerating AI adoption and monetization, with Cognigy driving growth. NICE also secured significant deals, including an 8-digit ACV deal with a global telecommunications provider.

$NICEMedAI 8/10

NiCE Q3 Earnings Call Highlights

NiCE reported Q3 AI revenue growth of 46% YoY to $392M, with cloud revenue at 16%. CXone backlog grew 27% YoY. Cloud growth was below expectations, but international revenue rose 33%. Non-GAAP operating margin was 27%. The company maintained its 2026 revenue outlook of $3.17B-$3.19B and raised adjusted EPS guidance to $11.12-$11.32.